It's good to see that Merck is starting a new phase II trial of Cavatak(V937)/Keytruda in advanced melanoma .... I was worried that they had shelved the product.
https://clinicaltrials.gov/ct2/show/NCT04152863?term=cavatak&recrs=abc&draw=2&rank=1
.
Add to My Watchlist
What is My Watchlist?